This is an RSS newsfeed from BioMed Central It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit http://www.biomedcentral.com/info/about/rss/ Current Opinion in Investigational Drugs - Latest articles http://thomsoncurrentdrugs.com/products/journals/coid The latest articles from Current Opinion in Investigational Drugs (ISSN 1472-4472) published by Current Drugs Limited. Tolevamer, an orally administered, toxin-binding polymer for Clostridium difficile-associated diarrhea http://www.biomedcentral.com/1472-4472/9/913 N Scheinfeld and K Biggers Current Opinion in Investigational Drugs 2008, 9:913-924 2008-07-25 doi:10.1186/cd-928103 Current Opinion in Investigational Drugs 1472-4472 9 913 2008-07-25 Rilpivirine, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV infection http://www.biomedcentral.com/1472-4472/9/899 D Ripamonti and F Maggiolo Current Opinion in Investigational Drugs 2008, 9:899-912 2008-07-25 doi:10.1186/cd-928101 Current Opinion in Investigational Drugs 1472-4472 9 899 2008-07-25 Raltegravir, an HIV-1 integrase inhibitor for HIV infection http://www.biomedcentral.com/1472-4472/9/885 C Cabrera Current Opinion in Investigational Drugs 2008, 9:885-898 2008-07-25 doi:10.1186/cd-928098 Current Opinion in Investigational Drugs 1472-4472 9 885 2008-07-25 Daptomycin, a lipopeptide antibiotic in clinical practice http://www.biomedcentral.com/1472-4472/9/879 F Weis, A Beiras-Fernandez and G Schelling Current Opinion in Investigational Drugs 2008, 9:879-884 2008-07-25 doi:10.1186/cd-928118 Current Opinion in Investigational Drugs 1472-4472 9 879 2008-07-25 Investigational antimicrobial drugs for bloodstream infections http://www.biomedcentral.com/1472-4472/9/871 IP Korbila and ME Falagas Current Opinion in Investigational Drugs 2008, 9:871-878 2008-07-25 doi:10.1186/cd-928095 Current Opinion in Investigational Drugs 1472-4472 9 871 2008-07-25 An update on the development of drugs against smallpox http://www.biomedcentral.com/1472-4472/9/865 Y-C Tse-Dinh Current Opinion in Investigational Drugs 2008, 9:865-870 2008-07-25 doi:10.1186/cd-928092 Current Opinion in Investigational Drugs 1472-4472 9 865 2008-07-25 Signaling cascades as drug targets in model and pathogenic fungi http://www.biomedcentral.com/1472-4472/9/856 RJ Bastidas, JL Reedy, H Morales-Johansson, J Heitman and ME Cardenas Current Opinion in Investigational Drugs 2008, 9:856-864 2008-07-25 doi:10.1186/cd-928089 Current Opinion in Investigational Drugs 1472-4472 9 856 2008-07-25 New developments in vaccines against respiratory viruses http://www.biomedcentral.com/1472-4472/9/846 M Wroblewska Current Opinion in Investigational Drugs 2008, 9:846-855 2008-07-25 doi:10.1186/cd-928085 Current Opinion in Investigational Drugs 1472-4472 9 846 2008-07-25 Recombinant vaccines for influenza virus http://www.biomedcentral.com/1472-4472/9/836 RA Tripp and SM Tompkins Current Opinion in Investigational Drugs 2008, 9:836-845 2008-07-25 doi:10.1186/cd-928084 Current Opinion in Investigational Drugs 1472-4472 9 836 2008-07-25 Respiration consists of two acts: First inspiration, then expect(or)ation… http://www.biomedcentral.com/1472-4472/9/833 T Jones Current Opinion in Investigational Drugs 2008, 9:833-835 2008-07-25 doi:10.1186/cd-928082 Current Opinion in Investigational Drugs 1472-4472 9 833 2008-07-25 Patent alert http://www.biomedcentral.com/1472-4472/9/822 HAM Mucke, P Norman, C Whelan and C Yeates Current Opinion in Investigational Drugs 2008, 9:822-832 2008-07-25 doi:10.1186/cd-928080 Current Opinion in Investigational Drugs 1472-4472 9 822 2008-07-25 Paper alert http://www.biomedcentral.com/1472-4472/9/813 SA Antoniu, M Daneshtalab, S Doggrell, MJ Elices, RE Hurst, N Levens and M Williams Current Opinion in Investigational Drugs 2008, 9:813-821 2008-07-25 doi:10.1186/cd-928076 Current Opinion in Investigational Drugs 1472-4472 9 813 2008-07-25 AL-108 and AL-208, formulations of the neuroprotective NAP fragment of activity-dependent neuroprotective protein, for cognitive disorders http://www.biomedcentral.com/1472-4472/9/800 H Geerts Current Opinion in Investigational Drugs 2008, 9:800-811 2008-07-01 doi:10.1186/cd-921661 Current Opinion in Investigational Drugs 1472-4472 9 800 2008-07-01